Skip to main content

Prof. Dr. med. Achim Hörauf

Member, Steering-Committee Member

Medical Microbiology, Immunology and Parasitology

Medical Faculty, University of Bonn University Hospital of Bonn Sigmund-Freud-Strasse 25 53127 Bonn

achim.hoerauf@ukbonn.de

Website

Prof. Hörauf is internationally renowned for his work in Tropical Medicine, in particular for pioneering new drug treatments against filariasis (a group of neglected tropical diseases). The new treatment exploits an endosymbiosis between worms and bacterial endosymbionts called Wolbachia, which are susceptible to some classes of antibiotics. Prof. Hörauf’s group was the first to characterize a TLR2 ligand from Wolbachia and established that blindness in onchocerciasis (or ‘river blindness’) is dependent on innate immune reactions against Wolbachia. They were the first to detect regulatory T cells in humans in an infection. Modulation of host’s immune responses is another focus of Prof. Hörauf’s group, demonstrating that filarial infection and filarial antigen treatment protects against type 1 diabetes onset and improves glucose tolerance during obesity. Using expression quantitative trait loci analysis, the role of genetic factors in modulating cellular responses (to filarial antigens) and eventually filariae-caused pathology devel-opment is currently investigated. Beyond immunology, Achim Hoerauf has preclinically developed 4 new drugs against human filariasis which are now in clinical phase 1 and 2 studies, together with DNDi and pharma partners such as Abbvie, Bayer, and Esai.

Recent publications

  • Molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli among children and farm animals in Agogo, Ghana.

    BMC microbiology

    Authors: Charity Wiafe Akenten, Hagen Frickmann, Thorsten Thye, Neyaz Ahmed Khan, Ralf Krumkamp, Ellis Kobina Paintsil, Linda Aurelia Ofori, Anna Jaeger, Wibke Loag, Maike Lamshoeft, Ernst Molitor, Achim Hoerauf, Kwasi Obiri-Danso, Stefan Berg, Oumou Maiga Ascofare, Richard Odame Phillips, Jürgen May, Denise Dekker

    View this publication
  • Corallopyronin A exhibits potent activity against staphylococci including MRSA and isolates from prosthetic infections.

    Infection

    Authors: Jesenko Karačić, Miriam Grosse, Kenneth Pfarr, Andrea Schiefer, Tanja Schneider, Achim Hoerauf, Sabina Karačić, Marijo Parčina, Gunnar Hischebeth, Frank Sebastian Fröschen, Gabriele Bierbaum

    View this publication
  • Establishing a filarial clinical research platform in a resource-limited setting: Lessons and experiences from Tanzania.

    PLoS neglected tropical diseases

    Authors: Ndekya M Oriyo, Michael A Munga, Abdallah Ngenya, John Ogondiek, Wilfred Mandara, Winfrida Shirima, Jonathan Akyoo, Ruth Laizer, Mathias Kamugisha, Hanifa Kapera, Rafikieli Ngwatu, Gracia Sanga, Jacklina Mhidze, Antelmo Haule, Anja Feichtner, Haile Mposheleye, Farida A Mwanga, Hatima A Chinguile, Alexander J Makalla, Peter Mabenga, Max Demetrius, Maureen M Mosoba, Dennis Moshi, Yusuph Mgaya, Linda Batsa Debrah, Inge Kroidl, Ute Klarmann-Schulz, Samuel Wanji, Alexander Yaw Debrah, Achim Hoerauf, Akili Kalinga, Upendo Mwingira

    View this publication